<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83075</article-id><article-id pub-id-type="doi">10.7554/eLife.83075</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-291173"><name><surname>Liu</surname><given-names>Cong</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2852-8953</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292365"><name><surname>Schönke</surname><given-names>Milena</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292366"><name><surname>Spoorenberg</surname><given-names>Borah</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292367"><name><surname>Lambooij</surname><given-names>Joost M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292368"><name><surname>van der Zande</surname><given-names>Hendrik JP</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292369"><name><surname>Zhou</surname><given-names>Enchen</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3739-4934</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-292370"><name><surname>Tushuizen</surname><given-names>Maarten E</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100297"><name><surname>Andreasson</surname><given-names>Anne-Christine</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8323-0658</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-292372"><name><surname>Park</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-292373"><name><surname>Oldham</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-292374"><name><surname>Uhrbom</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-100293"><name><surname>Ahlstedt</surname><given-names>Ingela</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-292375"><name><surname>Ikeda</surname><given-names>Yasuhiro</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-292376"><name><surname>Wallenius</surname><given-names>Kristina</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3231-2733</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-202788"><name><surname>Peng</surname><given-names>Xiao-Rong</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-187811"><name><surname>Guigas</surname><given-names>Bruno</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-33258"><name><surname>Boon</surname><given-names>Mariëtte R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-292377"><name><surname>Wang</surname><given-names>Yanan</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-33257"><name><surname>Rensen</surname><given-names>Patrick CN</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8455-4988</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Medicine</institution>, <institution>Leiden University Medical Center</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff2"><institution content-type="dept">Department of Parasitology</institution>, <institution>Leiden University Medical Center</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff3"><institution content-type="dept">5Department of Gastroenterology and Hepatology</institution>, <institution>Leiden University Medical Center</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff4"><institution content-type="dept">Research and Early Development</institution>, <institution>AstraZeneca</institution>, <addr-line><named-content content-type="city">Gothenburg</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff5"><institution content-type="dept">Biologics Engineering and Targeted Delivery</institution>, <institution>AstraZeneca</institution>, <addr-line><named-content content-type="city">Gaithersburg</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Research and Early Development</institution>, <institution>AstraZeneca</institution>, <addr-line><named-content content-type="city">Gaithersburg</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Endocrinology</institution>, <institution>First Affiliated Hospital of Xi'an Jiaotong University</institution>, <addr-line><named-content content-type="city">Xi'an</named-content></addr-line>, <country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-262226"><name><surname>Mistry</surname><given-names>Pramod</given-names></name><role>Reviewing editor</role><aff><institution>Yale School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>m.r.boon@lumc.nl</email> (MB);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>y_wang@xjtufh.edu.cn</email> (YW);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>p.c.n.rensen@lumc.nl</email> (PR);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>01</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e83075</elocation-id><history><date date-type="received"><day>30</day><month>08</month><year>2022</year></date><date date-type="accepted"><day>16</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Liu et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Liu et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83075-v1.pdf"/><abstract><p>Analogues of the hepatokine FGF21 are in clinical development for type 2 diabetes and nonalcoholic steatohepatitis (NASH) treatment. Although their glucose-lowering and insulin-sensitizing effects have been largely unraveled, the mechanisms by which they alleviate liver injury have only been scarcely addressed. Here, we aimed to unveil the mechanisms underlying the protective effects of FGF21 on NASH using APOE*3-Leiden.CETP mice, a well-established model for human-like metabolic diseases. Liver-specific FGF21 overexpression was achieved in mice, followed by administration of a high-fat high-cholesterol diet for 23 weeks. FGF21 prevented hepatic lipotoxicity, accompanied by activation of thermogenic tissues and attenuation of adipose tissue inflammation, improvement of hyperglycemia and hypertriglyceridemia, and upregulation of hepatic programs involved in fatty acid oxidation and cholesterol removal. Furthermore, FGF21 inhibited hepatic inflammation, as evidenced by reduced Kupffer cell (KC) activation, diminished monocyte infiltration and lowered accumulation of monocyte-derived macrophages. Moreover, FGF21 decreased lipid- and scar-associated macrophages, which correlated with less hepatic fibrosis as demonstrated by reduced collagen accumulation. Collectively, hepatic FGF21 overexpression limits hepatic lipotoxicity, inflammation and fibrogenesis. Mechanistically, FGF21 blocks hepatic lipid influx and accumulation through combined endocrine and autocrine signaling, respectively, which prevents KC activation and lowers the presence of lipid- and scar-associated macrophages to inhibit fibrogenesis.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003092</institution-id><institution>Diabetes Fonds</institution></institution-wrap></funding-source><award-id>2015.81.1808</award-id><principal-award-recipient><name><surname>Boon</surname><given-names>Mariëtte R</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>The Netherlands Organisation for Scientific Research-NWO</institution></institution-wrap></funding-source><award-id>VENI grant 91617027</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Yanan</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Chinese Scholarship Council grant</institution></institution-wrap></funding-source><award-id>CSC 201606010321</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Enchen</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>The Novo Nordisk Foundation</institution></institution-wrap></funding-source><award-id>NNF18OC0032394</award-id><principal-award-recipient><name><surname>Schönke</surname><given-names>Milena</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>The Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foundation</institution></institution-wrap></funding-source><award-id>CVON-GENIUS-2</award-id><principal-award-recipient><name><surname>Rensen</surname><given-names>Patrick CN</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Anne-Christine Andreasson, employee of AstraZeneca.</p></fn><fn fn-type="conflict" id="conf3"><p>Andrew Park, employee of AstraZeneca.</p></fn><fn fn-type="conflict" id="conf4"><p>Stephanie Oldham, employee of AstraZeneca.</p></fn><fn fn-type="conflict" id="conf5"><p>Martin Uhrbom, employee of AstraZeneca.</p></fn><fn fn-type="conflict" id="conf6"><p>Ingela Ahlstedt, employee of AstraZeneca.</p></fn><fn fn-type="conflict" id="conf7"><p>Yasuhiro Ikeda, employee of AstraZeneca.</p></fn><fn fn-type="conflict" id="conf8"><p>Kristina Wallenius, employee of AstraZeneca.</p></fn><fn fn-type="conflict" id="conf9"><p>Xiao-Rong Peng, employee of AstraZeneca.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were carried out according to the Institute for Laboratory Animal Research Guide for the Care and Use of Laboratory Animals, and were approved by the National Committee for Animal Experiments (Protocol No. AVD1160020173305) and by the Ethics Committee on Animal Care and Experimentation of the Leiden University Medical Center (Protocol No. PE.18.034.041).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file.</p></sec><supplementary-material><ext-link xlink:href="elife-83075-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>